Company Filing History:
Years Active: 2025
Title: Onno Wouter Kranenburg: Innovator in Antibody Development
Introduction
Onno Wouter Kranenburg is a notable inventor based in Zeist, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of multispecific antibodies. His work focuses on therapeutic applications, especially in cancer treatment.
Latest Patents
Kranenburg holds a patent for "Antibodies binding to fibroblast activation protein alpha and death receptor 4." This invention relates to a multispecific antibody that includes a FAPα binding region and a DR4 binding region. The patent outlines the pharmaceutical compositions that comprise these antibodies and their use in therapeutic and diagnostic procedures, particularly in cancer therapy. He has 1 patent to his name.
Career Highlights
Kranenburg is associated with Genmab A/S, a leading biotechnology company specializing in the development of innovative antibody therapeutics. His role at Genmab has allowed him to contribute to groundbreaking research and advancements in the field.
Collaborations
Throughout his career, Kranenburg has collaborated with esteemed colleagues such as Bart Ecg De Goeij and Ilse Jongerius. These collaborations have further enhanced the impact of his work in antibody development.
Conclusion
Onno Wouter Kranenburg is a prominent figure in the field of biotechnology, with a focus on innovative antibody therapies. His contributions are paving the way for advancements in cancer treatment and diagnostics.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.